>細(xì)胞CELL>ATCC腫瘤細(xì)胞>CHP-212
是否是腫瘤細(xì)胞:1
物種來源:人
數(shù)量:大量
生長狀態(tài):貼壁生長
運輸方式:凍存運輸
細(xì)胞形態(tài):神經(jīng)母細(xì)胞
ATCC Number:CRL-2273?
相關(guān)疾?。荷窠?jīng)母細(xì)胞瘤
器官來源:大腦
規(guī)格:48T Designations: CHP-212
Depositors: ?JL Biedler
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Homo sapiens
Morphology:neuroblast
Source: Organ: brain
Disease: neuroblastoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
DNA Profile (STR):Amelogenin: X,Y
CSF1PO: 12
D13S317: 8,13
D16S539: 13
D5S818: 10,12
D7S820: 11
THO1: 6
TPOX: 8,11
vWA: 15,18
Propagation: ATCC complete growth medium: The base medium for this cell line is a 1:1 mixture of ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003, and F12 Medium. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Protocol:
Subcultivation Ratio: A subcultivation ratio of 1:10 to 1:50 is recommended every 2 to 3 weeks
Medium Renewal: Every 2 to 3 days
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products:recommended serum:ATCC 30-2020